Trending...
- Cancer Survivor Roslyn Franken Marks 30-Year Milestone with Empowering Gift for Women Survivors
- RJ Grimshaw Launches "The AI EDGE" A Practical Guide Where Leadership Meets Innovation
- Live Good Leads with Love: Creating Opportunity, Protecting the Vulnerable and Inspiring Hope
WAUKESHA, Wis., Aug. 11, 2020 /PRNewswire/ -- Surfacide, a leading UV-C decontamination technology company, announces it has been awarded a contract with Vizient, the largest member-driven healthcare performance improvement company in the country, for Surfacide's innovative multiple emitter UV-C solution. The contract went into July 1.
Vizient serves more than half of the healthcare organizations across the United States – from large integrated delivery networks and academic medical centers to community hospitals, pediatric facilities and non-acute care providers. The contract will allow Vizient members greater access to a solution that has become an integral part to protecting both patients and staff during uncertain times.
While the agreement shows Surfacide's broader commitment to provide Vizient members with evidence-based and cutting-edge solutions at contracted pricing, the launch of the agreement is very timely in the wake of COVID-19. The Surfacide system, which demonstrated efficacy against the MERS Coronavirus in data published from the University of Iowa, is being deployed in facilities across the country as organizations implement solutions in the battle against COVID-19. While the implementation of Surfacide has been in response to the pandemic, many have noted this will be a long-term solution as the mindset around infection prevention has forever changed. The Surfacide system provides an automated UV-C decontamination technology that significantly reduces bacteria, spores and viruses and is effective against a variety of advanced viral infectious diseases. Helios incorporates multiple automated UV-C emitters that work together to provide decontamination of the room in minutes to provide an extra layer of protection.
More on Wisconsin Eagle
"Surfacide is proud of this contract with Vizient and proud to answer the urgent call from countless healthcare facilities that need a solution they can trust to deliver protection for healthcare workers and patients," says Gunner Lyslo, Founder and CEO of Surfacide. "Over the course of the last few months, we've seen UV-C technology emerge as a key tactic in combating coronavirus and other infections. We are confident that Surfacide's agreement with Vizient will allow more healthcare centers to have access to the Surfacide UV-C solution and slow the spread of COVID-19."
About Surfacide LLC
Surfacide LLC and Surfacide Manufacturing Inc., are located in Waukesha, WI and produce multiple emitter UV-C systems.
Surfacide is the only triple emitter UV-C system, providing the most efficient and flexible solution in the fight against viruses and other hospital-acquired infections. Over 400 hospitals nationally and internationally are using Surfacide technology to provide an extra layer of protection for patients and healthcare workers. Surfacide's evidence-based UV-C solution addresses shadows and provides greater coverage for quicker turnaround time and better care. Patients and healthcare workers around the world choose Surfacide as a trusted partner in infection prevention.
More on Wisconsin Eagle
Our mission is to provide patients and healthcare workers with a safe environment and continuous support in infection prevention. We respect and admire the dedication from healthcare professionals and in turn, deliver advanced technology that your team needs to provide the best care possible. Learn more about Surfacide by visiting https://surfacide.com or calling (844)-390-3538.
SOURCE Surfacide
Related Links
http://www.surfacide.com/
Vizient serves more than half of the healthcare organizations across the United States – from large integrated delivery networks and academic medical centers to community hospitals, pediatric facilities and non-acute care providers. The contract will allow Vizient members greater access to a solution that has become an integral part to protecting both patients and staff during uncertain times.
While the agreement shows Surfacide's broader commitment to provide Vizient members with evidence-based and cutting-edge solutions at contracted pricing, the launch of the agreement is very timely in the wake of COVID-19. The Surfacide system, which demonstrated efficacy against the MERS Coronavirus in data published from the University of Iowa, is being deployed in facilities across the country as organizations implement solutions in the battle against COVID-19. While the implementation of Surfacide has been in response to the pandemic, many have noted this will be a long-term solution as the mindset around infection prevention has forever changed. The Surfacide system provides an automated UV-C decontamination technology that significantly reduces bacteria, spores and viruses and is effective against a variety of advanced viral infectious diseases. Helios incorporates multiple automated UV-C emitters that work together to provide decontamination of the room in minutes to provide an extra layer of protection.
More on Wisconsin Eagle
- Multi-Signature Cold Storage: Keyanb Introduces Institutional-Grade Asset Protection for Chilean Crypto Traders
- NKSCX Introduces Zero-Knowledge Proof of Solvency for U.S. Traders Amid $6.5 Billion Fraud Crisis
- New Oasis International Foundation Announces Strategic Partnership Network Across 15 Countries to Advance Community-Led Economic Development
- PODS® Northeast Wisconsin Shares Smart Storage Solutions Before Winter Hits
- A Gift for You: Music, Story, and Hope for America: Free Download of The Human Renaissance Album
"Surfacide is proud of this contract with Vizient and proud to answer the urgent call from countless healthcare facilities that need a solution they can trust to deliver protection for healthcare workers and patients," says Gunner Lyslo, Founder and CEO of Surfacide. "Over the course of the last few months, we've seen UV-C technology emerge as a key tactic in combating coronavirus and other infections. We are confident that Surfacide's agreement with Vizient will allow more healthcare centers to have access to the Surfacide UV-C solution and slow the spread of COVID-19."
About Surfacide LLC
Surfacide LLC and Surfacide Manufacturing Inc., are located in Waukesha, WI and produce multiple emitter UV-C systems.
Surfacide is the only triple emitter UV-C system, providing the most efficient and flexible solution in the fight against viruses and other hospital-acquired infections. Over 400 hospitals nationally and internationally are using Surfacide technology to provide an extra layer of protection for patients and healthcare workers. Surfacide's evidence-based UV-C solution addresses shadows and provides greater coverage for quicker turnaround time and better care. Patients and healthcare workers around the world choose Surfacide as a trusted partner in infection prevention.
More on Wisconsin Eagle
- New You Smile Dental Implant Center Expands Office
- $8 Billion High-Margin National Gentlemen's Club Market Targeted by Acquisition Strategy Incorporating the Successful Peppermint Hippo™ Brand: $TRWD
- Why Indian Game Development Companies Are Shaping the Future of Global Gaming
- Cold Storage and Proof-of-Reserves: BTXSGG Launches Institutional-Grade Asset Protection for Filipino Traders
- Why FIRE Enthusiasts Are Buying Businesses Instead of Just Saving Their Way to Freedom
Our mission is to provide patients and healthcare workers with a safe environment and continuous support in infection prevention. We respect and admire the dedication from healthcare professionals and in turn, deliver advanced technology that your team needs to provide the best care possible. Learn more about Surfacide by visiting https://surfacide.com or calling (844)-390-3538.
SOURCE Surfacide
Related Links
http://www.surfacide.com/
0 Comments
Latest on Wisconsin Eagle
- Thread Advisory Group Launches to Help Retailers Turn Strategy Into Lasting Results
- QView Medical and Eve Wellness Announce Partnership to Advance Direct-to-Consumer Breast Cancer Screening With FDA-Approved AI
- New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them
- Airbus Defence and Space and Omnitronics Sign MoU to Advance Interoperability in Critical Communications
- White Glove Restoration Sends "Help in Boxes" to Support Communities in Ghana
- NASA Agreements, New Ocean Exploration Applications Added to Partnerships with Defiant Space Corp and Emtel Energy USA for Solar Tech Leader: $ASTI
- Crank Up the Fun Factor with Fusion Plus Lightning Edition
- Chic and Secure: The Blue Luna Debuts Stylish Keychains with Purpose
- BEC Technologies Showcases Leadership in Private Broadband Ecosystem with Inclusion in UTC's Ecosystem Summary Report
- $500,000 in Stock Dividend for Shareholders in 2025 Sweetens The Pot on Success of Becoming Debt Free with No Convertible Notes or Warrants for $IQST
- Milwaukee Job Corps Center: Essential Workforce Training—Admissions Now Open
- Aissist.io Launches Hybrid AI Workforce to Solve AI Pilot Failure for Customer Support Automation
- Christy Sports Makes Snowsports More Accessible for Families to Get Outside Together
- MainConcept Completes Management Buyout to Become Independent Company
- LIB Industry Expands Full-Series Salt Spray Corrosion Test Chambers to Meet Global Testing Standards
- The Easy Way to Collect Every Wedding Photo from Your Guests - No App Needed
- REPRESENTATION REVOLUTION: FLM TV Network Launches as America's First Truly Diverse Broadcast Network
- MetroWest wellness: Holliston farmhouse spa unveils Centerpoint Studio
- Cancer Survivor Roslyn Franken Marks 30-Year Milestone with Empowering Gift for Women Survivors
- ENERGY33 Successfully Completes Second Engineering & Construction Management Contract for a 27MW STX Cogeneration Power Plant in Honduras